[iBET – ITQB NOVA Seminar] Developability Assessment of therapeutic Antibodies
Thorsten Lorenz, Novartis Pharma AG, Basel, Switzerland
| When |
31 May, 2016
from
12:00 pm to 01:00 pm |
|---|---|
| Where | Auditorium |
| Add event to your calendar |
iCal
|
iBET – ITQB NOVA Seminar
Title: Developability Assessment of therapeutic Antibodies - A concept for early Lead Selection
Speaker: Thorsten Lorenz
Affiliation: Group Head Developability Assessment 1, Integrated Biologics Profiling, Novartis Pharma AG, Basel – Switzerland.
Host: Manuel Carrondo
